Toyobo Co., Ltd.

Tokyo Stock Exchange 3101.T

Toyobo Co., Ltd. Current Liabilities for the year ending March 31, 2024: USD 1.22 B

Toyobo Co., Ltd. Current Liabilities is USD 1.22 B for the year ending March 31, 2024, a -20.18% change year over year. Current liabilities are obligations that are expected to be settled within one year, including accounts payable, short-term debt, and other current liabilities.
  • Toyobo Co., Ltd. Current Liabilities for the year ending March 31, 2023 was USD 1.52 B, a 26.43% change year over year.
  • Toyobo Co., Ltd. Current Liabilities for the year ending March 31, 2022 was USD 1.21 B, a 1.57% change year over year.
  • Toyobo Co., Ltd. Current Liabilities for the year ending March 31, 2021 was USD 1.19 B, a 4.35% change year over year.
  • Toyobo Co., Ltd. Current Liabilities for the year ending March 31, 2020 was USD 1.14 B, a -4.29% change year over year.
Key data
Date Current Liabilities Total Non-Current Liabilities Shareholders' Equity Long-Term Debt
Market news
Loading...
Tokyo Stock Exchange: 3101.T

Toyobo Co., Ltd.

CEO Mr. Ikuo Takeuchi
IPO Date Jan. 4, 2000
Location Japan
Headquarters 1-13-1 Umeda
Employees 10,668
Sector Materials
Industries
Description

Toyobo Co., Ltd. provides films and functional polymers, industrial materials, and healthcare and textile products worldwide. It offers industrial films, including PET films for liquid crystal display, optical, and other industrial use; and synthetic papers. The company also provides packaging films, such as PET, polyolefin, and nylon for food packaging, as well as heat-shrink PET films; functional polymers comprising engineering plastics, industrial adhesives, coatings, photo-sensitive printing plates, acrylate polymers, and electronic materials; rubber and coat processing; and pharmaceuticals intermediates. In addition, it offers functional fibers consisting of airbag fabrics; polyethylene and PBO fibers; functional filters for automobiles, indoor, and anti-pollution solvent adsorption materials and units; and fiber materials for automobile parts. Further, the company provides bio products, including enzymes for diagnostics, diagnostic systems, and reagents for research; artificial kidney hollow fibers; anti-clotting materials; seawater desalination modules; functional textiles for sports clothing, underwear, and uniforms; synthetic filaments; apparel under the Munsingwear brand; acrylic fibers under the Exlan brand; and acrylate fibers under the eks brand, as well as trades in textile products. Additionally, it operates as a contract manufacturer of injections. The company was founded in 1882 and is headquartered in Osaka, Japan.

StockViz Staff

January 16, 2025

Any question? Send us an email